The ORBERA is used to assist adult patients with a body mass index of 30 to 40 in weight loss and maintenance.
“While new to the United States, ORBERA is a weight loss device with more than 220,000 balloons distributed in over 80 countries and approximately 230 published papers documenting its clinical results,” said Todd Newton, CEO of Apollo Endosurgery.
More articles on gastroenterology:
Gastro Health acquires 3 private GI practices: 5 things to know
What do gastroenterologists do to relax?
5 GI physicians in the news – Aug. 7, 2015
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.